Ireland

--:--IST

Latest

Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide

Subscribe

← All Companies

🇩🇰 Pharma & Life Science Companies in Denmark

2 companies tracked in our directory. Denmark's life science sector is led by Novo Nordisk and Lundbeck, with Leo Pharma in dermatology, regulated by the Danish Medicines Agency (DKMA).

Clinical Trials in Denmark → EMA Approvals Tracker →

Showing 2 of 2 companies

No matching companies found.

Try clearing your filters or refining your search keywords.

Genmab

Biotech

🇩🇰 Copenhagen, Denmark 2,000 emp GMAB

Genmab is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.

30 trials · 1 Irish licence

Novo Nordisk A/S

Pharmaceutical

🇩🇰 Bagsvaerd, Denmark 64,000 emp NOVO

Novo Nordisk is a global healthcare company specializing in diabetes care, obesity management, hemophilia care, and growth hormone therapy.

132 trials · 140 Irish licences